Comparative efficacy of subcutaneous (CT-P13) and intravenous infliximab in adult patients with rheumatoid arthritis: a network meta-regression of individual patient data from two randomised trials.

Arthritis Res Ther · 2021 · PMC8051052 · PMID 33863352

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a numerical trendno p-value reported

The probability of achieving an ACR20 response, disease remission based on CDAI or SDAI, and Boolean remission were the only outcomes for which the effect of treatment was not statistically significantly different, although a numerical trend was observed in favour of CT-P13 SC.

also in 1,012 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.